Contact PD/PI: Nelson, David R Abstract: UF Clinical and Translational Science Award: Overall The mission of the UF CTSI is to improve human health by accelerating the translation of scientific discoveries and the implementation of evidence-based best practices for the diagnosis, treatment, prevention and cure of human disease. The CTSI will pursue four overarching strategic goals to advance its vision, each with related initiatives and milestones. Strategic Goal 1: Chart new pathways for developing the translational workforce. The CTSI is reshaping the pathways and support mechanisms for translational research careers through its novel interdisciplinary, competency-based training and professional development programs; partnerships with communities and historically black colleges and universities to enhance diversity; and unique team science learning opportunities and environments that bring together all disciplines and health professions to enrich the translational workforce at UF and across the CTSA network. Strategic Goal 2: Embed translational science throughout UF?s learning health system to support a continuous cycle of inquiry, innovation, and implementation. The CTSI has developed transformative infrastructure and translational science programs that integrate UF?s clinical and research enterprises to form a cohesive learning health system. The CTSI and UF Health will build on a strong translational science base to develop advanced data capabilities and an outstanding environment for work at the intersection of research and patient care, expand high-impact pilot programs to transform discovery and the translation of research to diverse health care settings, and continue to pioneer the clinical implementation of molecular medicine. Strategic Goal 3: Expand statewide collaborations and opportunities to advance a participant-centered research agenda that reflects the health priorities and diversity of Florida?s 19.9M people. The CTSI and its community research partner, Florida State University, have developed statewide programs and collaborations with a vision of ensuring all Floridians have a voice and opportunity to participate in research ? including community members, patients, caregivers, clinicians, policymakers, payers, and other stakeholders. The CTSI will work with its partners to integrate and expand statewide research infrastructure and collaborations to better engage and serve Florida's communities through translational science, and to develop Florida as a model, partner, and destination for studying and addressing the health care needs of a more diverse and older US population. Strategic Goal 4: Accelerate the collective impact of the CTSA network. The CTSI will collaborate with other CTSA hubs in the multi-directional development, evaluation, dissemination, and implementation of new methods and processes for improving the quality and efficiency of translational research. The CTSI will accomplish this through its strengths in multisite study support, the methods and practice of recruitment and retention of special populations, and novel clinical metabolomics and network science programs. Project Summary/Abstract Page 303 Contact PD/PI: Nelson, David R

Public Health Relevance

The University of Florida Clinical and Translational Science Institute (CTSI) is the academic hub for clinical and translational science throughout the University, and increasingly throughout Florida, the nation?s third most populous state. The CTSI will strive to improve human health by accelerating the translation of scientific discoveries and the implementation of evidence-based best practices for the diagnosis, treatment, prevention and cure of human disease. Project Narrative Page 304

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001427-04S1
Application #
9695474
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Brazhnik, Olga
Project Start
2015-08-15
Project End
2019-03-31
Budget Start
2018-07-01
Budget End
2019-03-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Baumert, Thomas F; Berg, Thomas; Lim, Joseph K et al. (2018) Status of Direct-acting Antiviral Therapy for HCV Infection and Remaining Challenges. Gastroenterology :
Zhang, Hansi; Guo, Yi; Li, Qian et al. (2018) An ontology-guided semantic data integration framework to support integrative data analysis of cancer survival. BMC Med Inform Decis Mak 18:41
Elding Larsson, Helena; Lynch, Kristian F; Lönnrot, Maria et al. (2018) Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 61:193-202
Tucker, C M; Williams, J L; Wippold, G M et al. (2018) Views of diverse primary care patients on the roles of healthcare providers and staff and the influence of other variables in their weight management. Clin Obes 8:11-20
Orlando, Lori A; Sperber, Nina R; Voils, Corrine et al. (2018) Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group. Genet Med 20:655-663
Lemas, Dominick J; Cardel, Michelle I; Filipp, Stephanie L et al. (2018) Objectively measured pediatric obesity prevalence using the OneFlorida Clinical Research Consortium. Obes Res Clin Pract :
Striley, Catherine W; Milani, Sadaf A; Kwiatkowski, Evan et al. (2018) Community perceptions related to brain donation: Evidence for intervention. Alzheimers Dement :
Webb, Fern J; Khubchandani, Jagdish; Striley, Catherine Woodstock et al. (2018) Correction to: Black-White Differences in Willingness to Participate and Perceptions About Health Research: Results from the Population-Based HealthStreet Study. J Immigr Minor Health :
Singh, Srishti; Lomelino, Carrie L; Mboge, Mam Y et al. (2018) Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site. Molecules 23:
Mangal, Naveen; James, Margaret O; Stacpoole, Peter W et al. (2018) Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children. J Clin Pharmacol 58:212-220

Showing the most recent 10 out of 602 publications